Hutchmed (HCM) reported 2024 earnings Wednesday of $0.22 per diluted American depositary share, down from $0.58 a year earlier.

Three analysts polled by FactSet expected $0.27.

Revenue for the year ended Dec. 31 was $630.2 million, down from $838 million a year earlier.

Analysts surveyed by FactSet expected $665.9 million.

The company said it had $836.1 million in cash, cash equivalents and short-term investments as of Dec. 31.